185 related articles for article (PubMed ID: 24064691)
1. Genomic basis of aromatase excess syndrome: recombination- and replication-mediated rearrangements leading to CYP19A1 overexpression.
Fukami M; Tsuchiya T; Vollbach H; Brown KA; Abe S; Ohtsu S; Wabitsch M; Burger H; Simpson ER; Umezawa A; Shihara D; Nakabayashi K; Bulun SE; Shozu M; Ogata T
J Clin Endocrinol Metab; 2013 Dec; 98(12):E2013-21. PubMed ID: 24064691
[TBL] [Abstract][Full Text] [Related]
2. Aromatase excess syndrome: a rare autosomal dominant disorder leading to pre- or peri-pubertal onset gynecomastia.
Fukami M; Miyado M; Nagasaki K; Shozu M; Ogata T
Pediatr Endocrinol Rev; 2014 Mar; 11(3):298-305. PubMed ID: 24716396
[TBL] [Abstract][Full Text] [Related]
3. Aromatase excess syndrome: identification of cryptic duplications and deletions leading to gain of function of CYP19A1 and assessment of phenotypic determinants.
Fukami M; Shozu M; Soneda S; Kato F; Inagaki A; Takagi H; Hanaki K; Kanzaki S; Ohyama K; Sano T; Nishigaki T; Yokoya S; Binder G; Horikawa R; Ogata T
J Clin Endocrinol Metab; 2011 Jun; 96(6):E1035-43. PubMed ID: 21470988
[TBL] [Abstract][Full Text] [Related]
4. An aroma of complexity: how the unique genetics of aromatase (CYP19A1) explain diverse phenotypes from hens and hyenas to human gynecomastia, and testicular and other tumors.
Stratakis CA
J Clin Endocrinol Metab; 2013 Dec; 98(12):4676-81. PubMed ID: 24311795
[No Abstract] [Full Text] [Related]
5. Aromatase excess syndrome in a Chinese boy due to a novel duplication at 15q21.2.
Tan X; Wu X; Chen J; Wu Y; Li S; Chen X; Zhang X
J Pediatr Endocrinol Metab; 2019 Jan; 32(1):85-88. PubMed ID: 30530883
[TBL] [Abstract][Full Text] [Related]
6. Local aromatase excess with recruitment of unusual promoters of
Deberles E; Durand I; Mittre H; Reznik Y; Morera J
J Pediatr Endocrinol Metab; 2022 Jul; 35(7):924-930. PubMed ID: 35667691
[TBL] [Abstract][Full Text] [Related]
7. Aromatase deficiency in a Chinese adult man caused by novel compound heterozygous CYP19A1 mutations: effects of estrogen replacement therapy on the bone, lipid, liver and glucose metabolism.
Chen Z; Wang O; Nie M; Elison K; Zhou D; Li M; Jiang Y; Xia W; Meng X; Chen S; Xing X
Mol Cell Endocrinol; 2015 Jan; 399():32-42. PubMed ID: 25301327
[TBL] [Abstract][Full Text] [Related]
8. Five new cases of 46,XX aromatase deficiency: clinical follow-up from birth to puberty, a novel mutation, and a founder effect.
Marino R; Perez Garrido N; Costanzo M; Guercio G; Juanes M; Rocco C; Ramirez P; Warman DM; Ciaccio M; Pena G; Feyling JG; Miras M; Rivarola MA; Belgorosky A; Saraco N
J Clin Endocrinol Metab; 2015 Feb; 100(2):E301-7. PubMed ID: 25415177
[TBL] [Abstract][Full Text] [Related]
9. Aromatase and estrogen receptor α deficiency.
Bulun SE
Fertil Steril; 2014 Feb; 101(2):323-9. PubMed ID: 24485503
[TBL] [Abstract][Full Text] [Related]
10. Aromatase deficiency owing to a functional variant in the placenta promoter and a novel missense mutation in the CYP19A1 gene.
Hauri-Hohl A; Meyer-Böni M; Lang-Muritano M; Hauri-Hohl M; Schoenle EJ; Biason-Lauber A
Clin Endocrinol (Oxf); 2011 Jul; 75(1):39-43. PubMed ID: 21521281
[TBL] [Abstract][Full Text] [Related]
11. Aromatase deficiency: a novel compound heterozygous mutation identified in a Chinese girl with severe phenotype and obvious maternal virilization.
Zhu WJ; Cheng T; Zhu H; Han B; Fan MX; Gu T; Zhao SX; Liu Y; Cheng KX; Song HD; Qiao J
Mol Cell Endocrinol; 2016 Sep; 433():66-74. PubMed ID: 27256151
[TBL] [Abstract][Full Text] [Related]
12. Aromatase Deficiency in Two Siblings with 46,XX Karyotype Raised as Different Genders: A Novel Mutation (p.R115X) in the
Özen S; Atik T; Korkmaz Ö; Onay H; Gökşen D; Özkınay F; Çoğulu Ö; Darcan Ş
J Clin Res Pediatr Endocrinol; 2020 Mar; 12(1):109-112. PubMed ID: 30968679
[TBL] [Abstract][Full Text] [Related]
13. Molecular bases and phenotypic determinants of aromatase excess syndrome.
Fukami M; Shozu M; Ogata T
Int J Endocrinol; 2012; 2012():584807. PubMed ID: 22319526
[TBL] [Abstract][Full Text] [Related]
14. A Novel Homozygous
Dursun F; Ceylaner S
J Clin Res Pediatr Endocrinol; 2019 May; 11(2):196-201. PubMed ID: 30074481
[TBL] [Abstract][Full Text] [Related]
15. Long-term Effect of Aromatase Inhibition in Aromatase Excess Syndrome.
Binder G; Nakamura A; Schweizer R; Ogata T; Fukami M; Nagasaki K
J Clin Endocrinol Metab; 2021 Apr; 106(5):1491-1500. PubMed ID: 33513243
[TBL] [Abstract][Full Text] [Related]
16. Lack of genomic rearrangements involving the aromatase gene CYP19A1 in breast cancer.
Fukami M; Suzuki J; Nakabayashi K; Tsunashima R; Ogata T; Shozu M; Noguchi S
Breast Cancer; 2014 May; 21(3):382-5. PubMed ID: 23625277
[TBL] [Abstract][Full Text] [Related]
17. Aromatase Deficiency due to a Homozygous CYP19A1 Mutation in a 46,XX Egyptian Patient with Ambiguous Genitalia.
Mazen I; McElreavey K; Elaidy A; Kamel AK; Abdel-Hamid MS
Sex Dev; 2017; 11(5-6):275-279. PubMed ID: 29324451
[TBL] [Abstract][Full Text] [Related]
18. Aromatase Deficiency due to a Novel Mutation in
Unal E; Yıldırım R; Taş FF; Demir V; Onay H; Haspolat YK
J Clin Res Pediatr Endocrinol; 2018 Nov; 10(4):377-381. PubMed ID: 29553041
[TBL] [Abstract][Full Text] [Related]
19. Aromatase deficiency, a rare syndrome: case report.
Baykan EK; Erdoğan M; Özen S; Darcan Ş; Saygılı LF
J Clin Res Pediatr Endocrinol; 2013; 5(2):129-32. PubMed ID: 23748068
[TBL] [Abstract][Full Text] [Related]
20. Aromatase deficiency: rare cause of virilization.
Ludwikowski B; Heger S; Datz N; Richter-Unruh A; González R
Eur J Pediatr Surg; 2013 Oct; 23(5):418-22. PubMed ID: 23093430
[No Abstract] [Full Text] [Related]
[Next] [New Search]
